TrialInternational journal of hematology2009

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.

Yee Chung Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.